Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Walker

Showing results (61-70 of 137) with videos related to

Pageof 14
Sort By:
Molecular Therapy. Oncology|April 9, 2025
The oligosaccharyltransferase complex is an essential component of multiple myeloma plasma cellsHong Phuong Nguyen, Enze Liu, Anh Quynh Le, et al.
Plos One|June 14, 2014
A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction with the SMN complexFabio Mirabella, Alexander Murison, Lauren I Aronson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 18, 2011
Gender disparities in the tumor genetics and clinical outcome of multiple myelomaKevin D Boyd, Fiona M Ross, Laura Chiecchio, et al.
European Journal of Haematology|May 10, 2016
Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significanceAneta Mikulasova, Jan Smetana, Marketa Wayhelova, et al.
Blood Cancer Journal|August 11, 2019
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q SyndromeJeffrey R Sawyer, Erming Tian, Brian A Walker, et al.
Nature Communications|May 16, 2024
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myelomaTravis S Johnson, Parvathi Sudha, Enze Liu, et al.
Oncotarget|April 14, 2017
Search for rare protein altering variants influencing susceptibility to multiple myelomaMatthew Scales, Daniel Chubb, Sara E Dobbins, et al.
Genome Medicine|February 2, 2022
Diagnostic Evidence GAuge of Single cells (DEGAS): a flexible deep transfer learning framework for prioritizing cells in relation to diseaseTravis S Johnson, Christina Y Yu, Zhi Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcomeNicholas J Dickens, Brian A Walker, Paola E Leone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2011
Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survivalKevin D Boyd, Fiona M Ross, Brian A Walker, et al.
Pageof 14

Showing results (61-70 of 137) with videos related to

Sort By:
Pageof 14
Molecular Therapy. Oncology|April 9, 2025
The oligosaccharyltransferase complex is an essential component of multiple myeloma plasma cellsHong Phuong Nguyen, Enze Liu, Anh Quynh Le, et al.
Plos One|June 14, 2014
A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction with the SMN complexFabio Mirabella, Alexander Murison, Lauren I Aronson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 18, 2011
Gender disparities in the tumor genetics and clinical outcome of multiple myelomaKevin D Boyd, Fiona M Ross, Laura Chiecchio, et al.
European Journal of Haematology|May 10, 2016
Genomewide profiling of copy-number alteration in monoclonal gammopathy of undetermined significanceAneta Mikulasova, Jan Smetana, Marketa Wayhelova, et al.
Blood Cancer Journal|August 11, 2019
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q SyndromeJeffrey R Sawyer, Erming Tian, Brian A Walker, et al.
Nature Communications|May 16, 2024
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myelomaTravis S Johnson, Parvathi Sudha, Enze Liu, et al.
Oncotarget|April 14, 2017
Search for rare protein altering variants influencing susceptibility to multiple myelomaMatthew Scales, Daniel Chubb, Sara E Dobbins, et al.
Genome Medicine|February 2, 2022
Diagnostic Evidence GAuge of Single cells (DEGAS): a flexible deep transfer learning framework for prioritizing cells in relation to diseaseTravis S Johnson, Christina Y Yu, Zhi Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcomeNicholas J Dickens, Brian A Walker, Paola E Leone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2011
Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survivalKevin D Boyd, Fiona M Ross, Brian A Walker, et al.
Pageof 14